119 related articles for article (PubMed ID: 36705364)
1. Association between HMGA1 and immunosuppression in hepatocellular carcinoma: A comprehensive bioinformatics analysis.
Zhu J; Zheng Y; Liu Y; Chen M; Liu Y; Li J
Medicine (Baltimore); 2023 Jan; 102(4):e32707. PubMed ID: 36705364
[TBL] [Abstract][Full Text] [Related]
2. ANP32A promotes the proliferation, migration and invasion of hepatocellular carcinoma by modulating the HMGA1/STAT3 pathway.
Tian Z; Liu Z; Fang X; Cao K; Zhang B; Wu R; Wen X; Wen Q; Shi H; Wang R
Carcinogenesis; 2021 Apr; 42(3):493-506. PubMed ID: 33332531
[TBL] [Abstract][Full Text] [Related]
3. Determination of high mobility group A1 (HMGA1) expression in hepatocellular carcinoma: a potential prognostic marker.
Chang ZG; Yang LY; Wang W; Peng JX; Huang GW; Tao YM; Ding X
Dig Dis Sci; 2005 Oct; 50(10):1764-70. PubMed ID: 16187170
[TBL] [Abstract][Full Text] [Related]
4. KIFC1 is activated by TCF-4 and promotes hepatocellular carcinoma pathogenesis by regulating HMGA1 transcriptional activity.
Teng K; Wei S; Zhang C; Chen J; Chen J; Xiao K; Liu J; Dai M; Guan X; Yun J; Xie D
J Exp Clin Cancer Res; 2019 Jul; 38(1):329. PubMed ID: 31340839
[TBL] [Abstract][Full Text] [Related]
5. HMGA1 Promotes Macrophage Recruitment via Activation of NF-
Chen J; Ji K; Gu L; Fang Y; Pan M; Tian S
J Immunol Res; 2022; 2022():4727198. PubMed ID: 35785026
[TBL] [Abstract][Full Text] [Related]
6. High expression of PDZ-binding kinase is correlated with poor prognosis and immune infiltrates in hepatocellular carcinoma.
Mu W; Xie Y; Li J; Yan R; Zhang J; Liu Y; Fan Y
World J Surg Oncol; 2022 Jan; 20(1):22. PubMed ID: 35065633
[TBL] [Abstract][Full Text] [Related]
7. Immune infiltration-associated serum amyloid A1 predicts favorable prognosis for hepatocellular carcinoma.
Zhang W; Kong HF; Gao XD; Dong Z; Lu Y; Huang JG; Li H; Yang YP
World J Gastroenterol; 2020 Sep; 26(35):5287-5301. PubMed ID: 32994688
[TBL] [Abstract][Full Text] [Related]
8. STARD5 as a potential clinical target of hepatocellular carcinoma.
Liu Q; Du X; Yu Z; Yao Q; Meng X; Zhang K; Zheng L; Hong W
Med Oncol; 2022 Jul; 39(10):156. PubMed ID: 35852638
[TBL] [Abstract][Full Text] [Related]
9. HMGA1 drives stem cell, inflammatory pathway, and cell cycle progression genes during lymphoid tumorigenesis.
Schuldenfrei A; Belton A; Kowalski J; Talbot CC; Di Cello F; Poh W; Tsai HL; Shah SN; Huso TH; Huso DL; Resar LM
BMC Genomics; 2011 Nov; 12():549. PubMed ID: 22053823
[TBL] [Abstract][Full Text] [Related]
10. Upregulation of Stress-Induced Protein Kinase CK1 Delta is associated with a Poor Prognosis for patients with Hepatocellular Carcinoma.
Zhang H; Qiu C; Zeng H; Zhu W; Lyu W; Lao X
Genet Test Mol Biomarkers; 2021 Jul; 25(7):504-514. PubMed ID: 34280005
[No Abstract] [Full Text] [Related]
11. Elevated expression of HMGA1 correlates with the malignant status and prognosis of non-small cell lung cancer.
Zhang Z; Wang Q; Chen F; Liu J
Tumour Biol; 2015 Feb; 36(2):1213-9. PubMed ID: 25344216
[TBL] [Abstract][Full Text] [Related]
12. HMGA1 Expression in Human Hepatocellular Carcinoma Correlates with Poor Prognosis and Promotes Tumor Growth and Migration in in vitro Models.
Andreozzi M; Quintavalle C; Benz D; Quagliata L; Matter M; Calabrese D; Tosti N; Ruiz C; Trapani F; Tornillo L; Fusco A; Heim MH; Ng CK; Pallante P; Terracciano LM; Piscuoglio S
Neoplasia; 2016 Dec; 18(12):724-731. PubMed ID: 27855356
[TBL] [Abstract][Full Text] [Related]
13. Reversal of HMGA1-Mediated Immunosuppression Synergizes with Immunogenic Magnetothermodynamic for Improved Hepatocellular Carcinoma Therapy.
Yan B; Liu C; Li H; Wen N; Jiao W; Wang S; Zhang Y; Zhang T; Zhang H; Lv Y; Fan H; Liu X
ACS Nano; 2023 May; 17(10):9209-9223. PubMed ID: 37162457
[TBL] [Abstract][Full Text] [Related]
14. HMGA1 participates in MHCC97H cell proliferation and invasion through the ILK/Akt/GSK3β signaling pathway.
Liu L; Zhang S; Hu L; Liu L; Guo W; Zhang J
Mol Med Rep; 2017 Dec; 16(6):9287-9294. PubMed ID: 29152644
[TBL] [Abstract][Full Text] [Related]
15. CXCL2/10/12/14 are prognostic biomarkers and correlated with immune infiltration in hepatocellular carcinoma.
Lin T; Zhang E; Mai PP; Zhang YZ; Chen X; Peng LS
Biosci Rep; 2021 Jun; 41(6):. PubMed ID: 34085699
[TBL] [Abstract][Full Text] [Related]
16. High mobility group A1 (HMGA1) protein and gene expression correlate with ER-negativity and poor outcomes in breast cancer.
Gorbounov M; Carleton NM; Asch-Kendrick RJ; Xian L; Rooper L; Chia L; Cimino-Mathews A; Cope L; Meeker A; Stearns V; Veltri RW; Bae YK; Resar LMS
Breast Cancer Res Treat; 2020 Jan; 179(1):25-35. PubMed ID: 31531802
[TBL] [Abstract][Full Text] [Related]
17. Correlation of zinc finger protein 2, a prognostic biomarker, with immune infiltrates in liver cancer.
Sun L; Lin Y; Wang G; Zhang L; Hu L; Lu Z
Biosci Rep; 2021 Jan; 41(1):. PubMed ID: 33439969
[TBL] [Abstract][Full Text] [Related]
18. HMGA1 Promotes Hepatic Metastasis of Colorectal Cancer by Inducing Expression of Glucose Transporter 3 (GLUT3).
Yang M; Guo Y; Liu X; Liu N
Med Sci Monit; 2020 Sep; 26():e924975. PubMed ID: 32989212
[TBL] [Abstract][Full Text] [Related]
19. Fra-1 Regulates the Expression of HMGA1, Which is Associated with a Poor Prognosis in Human Esophageal Squamous Cell Carcinoma.
Toyozumi T; Hoshino I; Takahashi M; Usui A; Akutsu Y; Hanari N; Murakami K; Kano M; Akanuma N; Suitoh H; Matsumoto Y; Sekino N; Komatsu A; Matsubara H
Ann Surg Oncol; 2017 Oct; 24(11):3446-3455. PubMed ID: 27882471
[TBL] [Abstract][Full Text] [Related]
20. Prognostic Significance of
Saed L; Jeleń A; Mirowski M; Sałagacka-Kubiak A
Int J Mol Sci; 2022 Jun; 23(13):. PubMed ID: 35805937
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]